Literature DB >> 26711204

[Effects of patient-controlled intravenous analgesia with dexmedetomidine and sufentanil on postoperative cognition in elderly patients after spine surgery].

Kun Wang1, Chengwen Li2, Jihong Shi, Hongtu Wei.   

Abstract

OBJECTIVE: To explore the effect of patient-controlled intravenous analgesia (PCIA) with dexmedetomidine and sufentanil on early postoperative cognition in elderly patients after spine surgery.
METHODS: One hundred fifty-two patients aged more than 60 yr with ASA I-III undergoing elective spine surgery were randomly assigned into two groups: Group S received PCIA with only sufentanil (n=77); Group D received PCIA with dexmedetomidine and sufentanil (n=75). The severity of pain at rest and upon movement was measured at 1, 2, 6, 12, 24 and 48 h after surgery using the 11-point numerical rating scale (NRS). Delirium was assessed daily within three days after surgery via the confusion assessment method. Cognitive function was measured at the day before surgery and at one week after surgery using a battery of neuropsychologic tests including Digit Span (forward and backward) subtests and Visual Retention and Paired Associate Verbal Learning subtests of Wechsler Memory Scale, Stroop Color Word Interference Test, Digit Symbol Substitution subtest of Wechsler Adult Intelligence Scale (DSST) and Trail Making Test (Part A).
RESULTS: The NRS scores at rest and upon movement at 6 to 48 h after surgery were lower in Group D than those in Group S (P<0.05). Postoperative delirium (POD) was present in 8 (10.4%) patients in Group S and 3 (4.0%) patients in Group D (χ2=4.206, P>0.05). Two patients with POD in Group S were treated with risperidone. Postoperative cognitive dysfunction (POCD) was present in 15 (19.5%) patients in Group S and 6 (8.0%) patients in Group D (χ2=4.206, P<0.05). Compared with the preoperative baselines, the scores of Digit Span backward, Visual Retention and DSST were significantly lower (3.7±1.3 vs 4.1±1.1, 7.7±2.0 vs 8.8±1.8, 25.2±7.8 vs 28.2±7.6; t=2.132, 3.585, 2.427, respectively, P<0.05) and the time to complete Stroop test was significantly longer in Group S (56.9±14.8 vs 50.2±14.7, t=-2.822, P<0.05), while only the score of Digit Span backward was significantly lower in Group D (3.6±1.2 vs 4.0±1.2, t=2.144, P<0.05).
CONCLUSION: Dexmedetomidine combined with sufentanil in postoperative PCIA can result in superior analgesia and improve early postoperative cognitive function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26711204

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  5 in total

1.  Effect of dexmedetomidine on postoperative cognitive dysfunction and inflammation in patients after general anaesthesia: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Wan Yang; Ling-Suo Kong; Xing-Xing Zhu; Rui-Xiang Wang; Ying Liu; Lan-Ren Chen
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

2.  Impact of dexmedetomidine supplemented analgesia on delirium in patients recovering from orthopedic surgery: A randomized controlled trial.

Authors:  Hong Hong; Da-Zhi Zhang; Mo Li; Geng Wang; Sai-Nan Zhu; Yue Zhang; Dong-Xin Wang; Daniel I Sessler
Journal:  BMC Anesthesiol       Date:  2021-09-13       Impact factor: 2.217

3.  Analgesic effects of sufentanil in combination with flurbiprofen axetil and dexmedetomidine after open gastrointestinal tumor surgery: a retrospective study.

Authors:  Fei Liu; Ting-Ting Li; Liu-Lin Xiong; Ting-Hua Wang; Lu Yin; Jin Huang; Yan-Jun Chen
Journal:  BMC Anesthesiol       Date:  2022-04-29       Impact factor: 2.376

Review 4.  Influence of dexmedetomidine on postoperative cognitive dysfunction in the elderly: A meta-analysis of randomized controlled trials.

Authors:  Hui Yu; Hui Kang; Jingxiu Fan; Ge Cao; Bin Liu
Journal:  Brain Behav       Date:  2022-07-10       Impact factor: 3.405

5.  Comparative effectiveness of pharmacological interventions to prevent postoperative delirium: a network meta-analysis.

Authors:  Sun-Kyung Park; Taeyoon Lim; Hyeyeon Cho; Hyun-Kyu Yoon; Ho-Jin Lee; Ji-Hyun Lee; Seokha Yoo; Jin-Tae Kim; Won Ho Kim
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.